NEW YORK (Reuters Health) – Ugandan HIV and AIDS patients receiving antiretroviral “cocktail” therapy can expect to live nearly as long as their compatriots who don’t have HIV, a new study finds.
“They can have almost a normal life expectancy, and live approximately two thirds as long as if they had not had HIV,” said Edward Mills, a professor of global health at the University of Ottawa in Canada and lead author of the study. “This is very good news.”
In the United States and other developed countries, combinations of antiretroviral therapies are known to increase the life spans of people with HIV to near-normal lengths, but how far these drugs can go in settings where patients don’t have excellent health care was unclear.
Mills and his colleagues looked at the health records of more than 20,000 people who received medications from The AIDS Support Organization in Uganda.
The total cost of an individual’s
Read More from the Article Source: http://us.rd.yahoo.com/dailynews/rss/health/*http%3A//news.yahoo.com/s/nm/20110722/hl_nm/us_uganda
